Dx dialogues: helping physicians identify patients for combination therapies with CAR-T
Douglas W. Sborov, MD shares tools for physicians to identify patients for combination therapies with CAR-T.
Up Next
Dx dialogues: versatile treatment options across the multiple myeloma landscape
Dx dialogues: post anti-CD38 therapy
Dx dialogues: identifying patients with cutaneous melanoma for TIL therapy
Dx dialogues: the importance of comprehensive testing in oncology
Dx dialogues: the impact of next-generation sequencing on clinical utility
Dx dialogues: HLA typing and patient selection with cutaneous melanoma
Dx dialogues: how AI might be used in the R/R AML space
Dx dialogues: using molecular profiling to identify mutations in R/R AML
Dx dialogues: the future of personalized ovarian response prediction
Dx dialogues: a potential paradigm shift in the treatment of metastatic breast cancer
